Profile of circulating cytokines: Impact of OSA, obesity and acute cardiovascular events

Cytokine

Volumn 62, Issue 2, 2013, Pages 210-216

  Testelmans, Dries ^a,b   Tamisier, Renaud ^b,c   Barone rochette, Gilles ^b   Baguet, Jean Philippe ^b   Roux Lombard, Pascale ^d   Pépin, Jean Louis ^b,c   Lévy, Patrick ^b,c  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c University Grenoble Alpes   (France)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Acute cardiovascular event; Inflammatory profile; Sleep apnea

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYTOKINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; ADULT; APNEA HYPOPNEA INDEX; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CAROTID ARTERY; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULSE WAVE; SLEEP DISORDERED BREATHING; BLOOD; CASE CONTROL STUDY; INFLAMMATION; METABOLISM; MIDDLE AGED; POLYSOMNOGRAPHY;

ADIPONECTIN; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; OBESITY; POLYSOMNOGRAPHY; SLEEP APNEA, OBSTRUCTIVE;

EID: 84876797630     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.02.021     Document Type: Article

References (49)

1. Marin J.M., Carrizo S.J., Vicente E., et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005, 365:1046-1053.
2. Somers V.K., White D.P., Amin R., et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J Am Coll Cardiol 2008, 52:686-717.
3. Gottlieb D.J., Yenokyan G., Newman A.B., et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation 2010, 122:352-360.
4. Redline S., Yenokyan G., Gottlieb D.J., et al. Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study. Am J Respir Crit Care Med 2010, 182:269-277.
5. Shahar E., Whitney C.W., Redline S., et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the sleep heart health study. Am J Respir Crit Care Med 2001, 163:19-25.
6. Yaggi H., Mohsenin V. Obstructive sleep apnoea and stroke. Lancet Neurol 2004, 3:333-342.
7. McNicholas W.T., Bonsigore M.R. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 2007, 29:156-178.
8. Lavie L., Lavie P. Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link. Eur Respir J 2009, 33:1467-1484.
9. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
10. Fisman E.Z., Benderly M., Esper R.J., et al. Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and/or healed myocardial infarction. Am J Cardiol 2006, 98:14-18.
11. Kablak-Ziembicka A., Przewlocki T., Sokolowski A., et al. Carotid intima-media thickness, hs-CRP and TNF-alpha are independently associated with cardiovascular event risk in patients with atherosclerotic occlusive disease. Atherosclerosis 2011, 214:185-190.
12. Kent B.D., Ryan S., McNicholas W.T. Obstructive sleep apnea and inflammation: Relationship to cardiovascular co-morbidity. Respir Physiol Neurobiol 2011, 178:475-481.
13. Kohler M., Ayers L., Pepperell J.C., et al. Effects of continuous positive airway pressure on systemic inflammation in patients with moderate to severe obstructive sleep apnoea: a randomised controlled trial. Thorax 2009, 64:67-73.
14. Ryan S., Taylor C.T., McNicholas W.T. Predictors of elevated nuclear factor-kappaB-dependent genes in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2006, 174:824-830.
15. Taheri S., Austin D., Lin L., et al. Correlates of serum C-reactive protein (CRP) - no association with sleep duration or sleep disordered breathing. Sleep 2007, 30:991-996.
16. Argod J., Pépin J.L., Lévy P. Differentiating obstructive and central sleep respiratory events through pulse transit time. Am J Respir Crit Care Med 1998, 158:1178-1183.
17. Bonnet M., Carley D., Carskadon M., et al. EEG arousals: Scoring rules and examples: a preliminary report from the sleep disorders atlas task force of the American sleep disorders association. Sleep 1992, 15:173-184.
18. Hosselet J.J., Norman R.G., Ayappa I., Rapoport D.M. Detection of flow limitation with a nasal cannula/pressure transducer system. Am J Respir Crit Care Med 1998, 157:1461-1467.
19. Laurent S., Cockcroft J., Van Bortel L., et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006, 27:2588-2605.
20. Baguet J.P., Nadra M., Barone-Rochette G., et al. Early cardiovascular abnormalities in newly diagnosed obstructive sleep apnea. Vasc Health Risk Manage 2009, 5:1063-1073.
21. Yip H.K., Hang C.L., Fang C.Y., et al. Level of high-sensitivity C-reactive protein is predictive of 30-day outcomes in patients with acute myocardial infarction undergoing primary coronary intervention. Chest 2005, 127:803-808.
22. Mouco O.M., Nicolau J.C., Souza Tda R., et al. Inflammatory markers of atherosclerotic plaque stabilization after acute coronary event--temporal trends. Arq Bras Cardiol 2006, 87:28-36.
23. Basaran Y., Basaran M.M., Babacan K.F., et al. Serum tumor necrosis factor levels in acute myocardial infarction and unstable angina pectoris. Angiology 1993, 44:332-337.
24. Sotgiu S., Zanda B., Marchetti B., et al. Inflammatory biomarkers in blood of patients with acute brain ischemia. Eur J Neurol 2006, 13:505-513.
25. Danesh J., Kaptoge S., Mann A.G., et al. Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med 2008, 5:e78.
26. Gossl M., Versari D., Hildebrandt H.A., et al. Segmental heterogeneity of vasa vasorum neovascularization in human coronary atherosclerosis. JACC Cardiovasc Imag 2010, 3:32-40.
27. Loppnow H., Werdan K., Buerke M. Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms. Innate Immun. 2008, 14:63-87.
28. Albert C.M., Ma J., Rifai N., et al. Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation 2002, 105:2595-2599.
29. Lakoski S.G., Cushman M., Criqui M., et al. Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort. Am Heart J 2006, 152:593-598.
30. Charles B.A., Doumatey A., Huang H., et al. The roles of IL-6, IL-10 and IL-1RA in obesity and insulin restistance in African-Americans. J Clin Endocrinol Metab 2011, 96:E2018-2022.
31. Kennedy A., Gettys T.W., Watson P., et al. The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J Clin Endocrinol Metab 1997, 82:1293-1300.
32. Considine R.V., Sinha M.K., Heiman M.L., et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996, 334:292-295.
33. Schaub N., Reichlin T., Meune C., et al. Markers of plaque instability in the early diagnosis and risk stratification of acute myocardial infarction. Clin Chem 2012, 58:246-256.
34. Kraaijeveld A.O., de Jager S.C., de Jager W.J., et al. CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptoms. Circulation 2007, 116:1931-1941.
35. Kobusiak-Prokopowicz M., Orzeszko J., Mazur G., et al. Chemokines and left ventricular function in patients with acute myocardial infarction. Eur J Intern Med 2007, 18:288-294.
36. Hegglin A., Schoch O.D., Korte W., et al. Eight months of CPAP decrease TNFA in men with obstructive sleep apnea syndrome. Sleep Breath 2012, 16:405-412.
37. Al Lawati N., Mulgrew A., Cheema R., et al. Pro-atherogenic cytokine profile of patients with suspected obstructive sleep apnea. Sleep Breath 2009, 13:391-395.
38. Arnaud C., Beguin P.C., Lantuejoul S., Pepin J.L., Guillermet C., Pelli G., et al. The inflammatory preatherosclerotic remodeling induced by intermittent hypoxia is attenuated by RANTES/CCL5 inhibition. Am J Respir Crit Care Med 2011, 184:724-731.
39. Borel J.C., Roux-Lombard P., Tamisier R., et al. Endothelial dysfunction and specific inflammation in obesity hypoventilation syndrome. PLoS One 2009, 4:e6733.
40. Harsch I.A., Wallaschofski H., Koebnick C., et al. Adiponectin in patients with obstructive sleep apnea syndrome: course and physiological relevance. Respiration 2004, 71:580-586.
41. Ridker P.M., Hennekens C.H., Roitman-Johnson B., et al. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 1998, 351:88-92.
42. El-Solh A.A., Mador M.J., Sikka P., et al. Adhesion molecules in patients with coronary artery disease and moderate-to-severe obstructive sleep apnea. Chest 2002, 121:1541-1547.
43. Ursavas A., Karadag M., Rodoplu E., et al. Circulating ICAM-1 and VCAM-1 levels in patients with obstructive sleep apnea syndrome. Respiration 2007, 74:525-532.
44. Chin K., Nakamura T., Shimizu K., et al. Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome. Am J Med 2000, 109:562-567.
45. Herrington D.M., Brown W.V., Mosca L., et al. Relationship between arterial stiffness and subclinical aortic atherosclerosis. Circulation 2004, 110:432-437.
46. Lorenz M.W., Markus H.S., Bots M.L., et al. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007, 115:459-467.
47. Korcarz C.E., Gepner A.D., Peppard P.E., et al. The effects of sleep-disordered breathing on arterial stiffness are modulated by age. Sleep 2010, 33:1081-1085.
48. Suzuki T., Nakano H., Maekawa J., et al. Obstructive sleep apnea and carotid-artery intima-media thickness. Sleep 2004, 27:129-133.
49. Cartier A., Côté M., Lemieux I., et al. Sex differences in inflammatory markers: what is the contribution of visceral adiposity?. Am J Clin Nutr 2009, 89:1307-1314.